Editorial: Recent advances in progestin-primed ovarian stimulation
Prif Awdur: | Qiuju Chen |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Frontiers Media S.A.
2022-11-01
|
Cyfres: | Frontiers in Endocrinology |
Pynciau: | |
Mynediad Ar-lein: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1004352/full |
Eitemau Tebyg
-
Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
gan: Tien K. Le, et al.
Cyhoeddwyd: (2024-03-01) -
Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
gan: Le Duc Thang, et al.
Cyhoeddwyd: (2024-04-01) -
Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
gan: Ai-Min Yang, et al.
Cyhoeddwyd: (2022-04-01) -
Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
gan: Angel Hsin-Yu Pai, et al.
Cyhoeddwyd: (2023-08-01) -
Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
gan: M. Martínez-Moya, et al.
Cyhoeddwyd: (2024-03-01)